Impact of six-week viral load on mortality in HIV-infected zimbabwean infants

Pediatric Infectious Disease Journal

Volumn 31, Issue 9, 2012, Pages 948-950

  Mutasa, Kuda ^a   Ntozini, Robert ^a   Prendergast, Andrew ^a,b,c   Iliff, Peter ^a   Rukobo, Sandra ^a   Moulton, Lawrence H ^c   Ward, Brian J ^d   Humphrey, Jean H ^a,b  

^a ZVITAMBO Project   (Zimbabwe)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

disease progression; HIV; infants; mortality; viral load

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT DISEASE; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; VIRUS LOAD; ZIMBABWE;

CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; VIRAL LOAD; ZIMBABWE;

EID: 84865504586     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318266aac2     Document Type: Article

References (12)

1. Abrams EJ, Weedon J, Steketee RW, et al. Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. J Infect Dis. 1998;178:101-108.
2. Dickover RE, Dillon M, Leung KM, et al. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis. 1998;178:375-387.
3. Obimbo EM, Wamalwa D, Richardson B, et al. Pediatric HIV-1 in Kenya: pattern and correlates of viral load and association with mortality. J Acquir Immune Defic Syndr. 2009;51:209-215.
4. Rouet F, Sakarovitch C, Msellati P, et al.; Abidjan ANRS 049 Ditrame Study Group. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics. 2003;112:e289.
5. Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med. 1997;336:1337-1342.
6. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. WHO, Geneva, 2010. Available at: http://www. who.int/hiv/pub/paediatric/infants2010/en/index.html. Accessed January 18, 2012.
7. Humphrey JH, Iliff PJ, Marinda ET, et al.; ZVITAMBO Study Group. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis. 2006;193:860-871.
8. Marinda E, Humphrey JH, Iliff PJ, et al.; ZVITAMBO Study Group. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J. 2007;26:519-526.
9. Kuhn L, Steketee RW, Weedon J, et al. Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study. J Infect Dis. 1999;179:52-58.
10. Mayaux MJ, Burgard M, Teglas JP, et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA. 1996;275:606-610.
11. Judd A; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord. Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens. AIDS. 2011;25:2279-2287.
12. Lennox JL, DeJesus E, Lazzarin A, et al.; STARTMRK investigators. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial. Lancet. 2009;374:796-806.